tiprankstipranks
Advertisement
Advertisement
Anika Therapeutics Earnings Call Signals Cautious Rebound
PremiumCompany AnnouncementsAnika Therapeutics Earnings Call Signals Cautious Rebound
2M ago
Anika Therapeutics price target raised to $17 from $16 at Barrington
Premium
The Fly
Anika Therapeutics price target raised to $17 from $16 at Barrington
3M ago
Anika Therapeutics price target raised to $18 from $16 at B. Riley
Premium
The Fly
Anika Therapeutics price target raised to $18 from $16 at B. Riley
3M ago
Anika Therapeutics Announces CEO Transition and Governance Changes
PremiumCompany AnnouncementsAnika Therapeutics Announces CEO Transition and Governance Changes
4M ago
Anika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair
Premium
The Fly
Anika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair
4M ago
Anika Therapeutics price target raised to $16 from $15 at Barrington
Premium
The Fly
Anika Therapeutics price target raised to $16 from $15 at Barrington
6M ago
Anika Therapeutics reaffirms FY25 guidance
PremiumThe FlyAnika Therapeutics reaffirms FY25 guidance
7M ago
Anika Therapeutics commences $15M 10b5-1 share repurchase
Premium
The Fly
Anika Therapeutics commences $15M 10b5-1 share repurchase
7M ago
Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year
Premium
The Fly
Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100